* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, June 14, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    The Media and Entertainment Deal Machine Is Revving Up – WSJ

    The Media and Entertainment Deal Machine Is Gearing Up for Action

    Op-Ed: Data Storage and Protection in Today’s Media & Entertainment Industry – Sports Video Group

    How Data Storage and Protection Are Transforming the Media & Entertainment Industry

    The Analyst Verdict: PENN Entertainment In The Eyes Of 7 Experts – Nasdaq

    7 Experts Reveal the Ultimate Verdict on PENN Entertainment

    3 Arts Entertainment Expands Into News With Acquisition of OManagement (Exclusive) – The Hollywood Reporter

    3 Arts Entertainment Expands Into News With Acquisition of OManagement (Exclusive) – The Hollywood Reporter

    Leading Proxy Advisory Firm Glass Lewis Recommends Shareholders Vote “FOR” Both of PENN Entertainment’s Director Nominees on the WHITE Proxy Card – Business Wire

    Glass Lewis Urges Shareholders to Support All PENN Entertainment Director Nominees on the WHITE Proxy Card

    Cisco Partners with Monumental Sports & Entertainment to Power New D.C. Arena – Cisco Newsroom

    Cisco Teams Up with Monumental Sports & Entertainment to Revolutionize the New D.C. Arena Experience

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    New Semiconductor Technology Could Supercharge 6G Delivery – SciTechDaily

    Revolutionary Semiconductor Technology Set to Turbocharge 6G Connectivity

    UTC To Host Quantum Technology Workshop June 23-25 – Chattanoogan.com: Breaking News

    Join the Quantum Technology Workshop This June 23-25!

    Rimac Technology Powers the Bugatti Tourbillon with Cutting-Edge Battery and Powertrain Tech – Rimac Newsroom

    Rimac Technology Drives the Bugatti Tourbillon with Revolutionary Battery and Powertrain Innovation

    “Co-creation” boosts commercial technology for dual-use defense applications – Breaking Defense

    “Co-creation” boosts commercial technology for dual-use defense applications – Breaking Defense

    MSI Viking and Mahr Host Technology Day – WSPA 7NEWS

    Step Inside the Thrilling World of MSI Viking and Mahr Technology Day!

    6.12pm is the new 8pm – Go Technology – cgastrategy.com

    6.12pm is the new 8pm – Go Technology – cgastrategy.com

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    The Media and Entertainment Deal Machine Is Revving Up – WSJ

    The Media and Entertainment Deal Machine Is Gearing Up for Action

    Op-Ed: Data Storage and Protection in Today’s Media & Entertainment Industry – Sports Video Group

    How Data Storage and Protection Are Transforming the Media & Entertainment Industry

    The Analyst Verdict: PENN Entertainment In The Eyes Of 7 Experts – Nasdaq

    7 Experts Reveal the Ultimate Verdict on PENN Entertainment

    3 Arts Entertainment Expands Into News With Acquisition of OManagement (Exclusive) – The Hollywood Reporter

    3 Arts Entertainment Expands Into News With Acquisition of OManagement (Exclusive) – The Hollywood Reporter

    Leading Proxy Advisory Firm Glass Lewis Recommends Shareholders Vote “FOR” Both of PENN Entertainment’s Director Nominees on the WHITE Proxy Card – Business Wire

    Glass Lewis Urges Shareholders to Support All PENN Entertainment Director Nominees on the WHITE Proxy Card

    Cisco Partners with Monumental Sports & Entertainment to Power New D.C. Arena – Cisco Newsroom

    Cisco Teams Up with Monumental Sports & Entertainment to Revolutionize the New D.C. Arena Experience

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    New Semiconductor Technology Could Supercharge 6G Delivery – SciTechDaily

    Revolutionary Semiconductor Technology Set to Turbocharge 6G Connectivity

    UTC To Host Quantum Technology Workshop June 23-25 – Chattanoogan.com: Breaking News

    Join the Quantum Technology Workshop This June 23-25!

    Rimac Technology Powers the Bugatti Tourbillon with Cutting-Edge Battery and Powertrain Tech – Rimac Newsroom

    Rimac Technology Drives the Bugatti Tourbillon with Revolutionary Battery and Powertrain Innovation

    “Co-creation” boosts commercial technology for dual-use defense applications – Breaking Defense

    “Co-creation” boosts commercial technology for dual-use defense applications – Breaking Defense

    MSI Viking and Mahr Host Technology Day – WSPA 7NEWS

    Step Inside the Thrilling World of MSI Viking and Mahr Technology Day!

    6.12pm is the new 8pm – Go Technology – cgastrategy.com

    6.12pm is the new 8pm – Go Technology – cgastrategy.com

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Adcetris Plus Chemo Effective in HIV-Related Hodgkin Lymphoma

August 7, 2023
in Health
Adcetris Plus Chemo Effective in HIV-Related Hodgkin Lymphoma
Share on FacebookShare on Twitter

Brentuximab vedotin (Adcetris) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) was effective for patients with HIV-related stages II-IV classical Hodgkin lymphoma (cHL), according to results from the phase I/II AMC-085 study.

All 37 patients who completed therapy in the 41-patient trial achieved a complete response; at 2 years, the progression-free survival (PFS) rate reached 87% (95% CI 71-94) and the overall survival (OS) rate was 92% (95% CI 79-97).

For stage III/IV HIV-cHL specifically, 2-year rates of PFS and OS were 87% and 90%, reported Paul G. Rubinstein, MD, of the University of Illinois in Chicago, and colleagues. Median follow-up for the analysis was 29 months.

“The data suggest that the outcomes are as good or better than other regimens in HIV-cHL and at least comparable with those without HIV,” the researchers wrote in The Lancet Haematology, adding that they believe the study is “practice changing.”

Four patients had progression of disease by the last data cut-off. One treatment-related death occurred due to febrile neutropenia in cycle one, while another patient who declined treatment after cycle one and withdrew from the study died of infectious complications 1 month after withdrawal.

The most common grade ≥3 adverse events with the combination of AVD plus brentuximab vedotin, an anti-CD30 antibody-drug conjugate, were peripheral sensory neuropathy in four patients (10%), neutropenia in 18 (44%), and febrile neutropenia in five (12%).

Rubinstein and co-authors noted that CD4+ and CD8+ T-cell counts increased in most patients, in contrast with decreases seen in cohorts treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), suggesting that the study may also have implications for people living with HIV in general. Few interventions aside from antiretroviral therapy itself have ever shown improved CD4+ T-cell counts in people living with HIV, the team explained.

Outside Experts Suggests Caution

Writing in an editorial accompanying the study, however, Christian Hoffmann, MD, PhD, of the University Hospital of Schleswig-Holstein in Kiel, Germany, and Marcus Hentrich, MD, of the University of Munich, wrote that while the data suggest that outcomes with brentuximab vedotin-AVD might be as good as those with other regimens and in people without HIV, the results should be treated with caution.

“Given one treatment-related death, four patients with progressive disease, and a 10% rate of grade 3 or worse peripheral sensory neuropathy (with three additional patients having to discontinue therapy due to toxicity), we believe it is too early to recommend brentuximab vedotin-AVD as ‘practice changing,'” Hoffmann and Hentrich said.

They also suggested that any improvement seen in OS with brentuximab vedotin-AVD compared with the standard ABVD regimen in patients with HIV-negative advanced cHL “should be weighed against the increased neurotoxicity and myelosuppression with brentuximab vedotin-AVD compared with ABVD; these adverse events should be kept into consideration especially for people living with HIV.”

However, the trial does mark another step towards optimizing treatment for HIV-associated cHL, the commentators said, adding that the results “also reemphasize the long-standing demand that people living with HIV should no longer be excluded from clinical lymphoma (and other cancer) trials.”

In explaining the rationale behind the study, Rubinstein and co-authors noted that HIV-associated cHL “remains one of the most common non-AIDS defining malignancies,” and that although outcomes for these patients have improved with the addition of antiretroviral therapy to HIV-cHL therapy, advanced-stage disease continues to have high relapse rates, warranting the need for new therapies.

Updated findings from the phase III ECHELON-1 trial showed that the 2-year PFS improvement with brentuximab vedotin plus AVD over ABVD (82.1% vs 77.2%) translated to an OS benefit at 6 years as well (93.9% vs 89.4%).

But people living with HIV were excluded from that trial, thus leading to the current single-arm trial.

The phase I/II study was conducted from 2013 to 2019 in the U.S. and France, and included 41 patients with CD30+ HIV-related cHL: seven (17%) had stage II unfavorable disease and 34 (83%) had stage III-IV disease. Participants had a median age of 48 years and 93% were male.

Patients were treated intravenously with 1.2 mg/kg of brentuximab vedotin with standard doses of AVD for six cycles on days 1 and 15 of a 28-day cycle.

author['full_name']

Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.

Disclosures

The study was funded by NIH and NCI and coordinated by the AIDS Malignancy Consortium, the AIDS Malignancy Consortium Lymphoma Working Group, and the Lymphoma Study Association.

Rubinstein, as well as several co-authors, reported receiving support through AIDS Malignancy Consortium grants; two co-authors reported relationships with industry.

Hoffmann and Hentrich had no disclosures.

Primary Source

The Lancet Haematology

Source Reference: Rubinstein P, et al “Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial” Lancet Haematol 2023; DOI:10.1016/S2352-3026(23)00157-6.

Secondary Source

The Lancet Haematology

Source Reference: Hoffmann C, Hentrich M “Optimising treatment of HIV-associated Hodgkin lymphoma” Lancet Haematol 2023; DOI:10.1016/S2352-3206(23)00177-1.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/hematologyoncology/lymphoma/105766

Tags: AdcetrisChemohealth
Previous Post

When It Comes to Eye Care, AI Couldn’t See Straight

Next Post

Prenatal Screening Sets Up Younger Babies for Heart Defect Surgery

New Semiconductor Technology Could Supercharge 6G Delivery – SciTechDaily

Revolutionary Semiconductor Technology Set to Turbocharge 6G Connectivity

June 14, 2025
Saturday Sports: It’s the finals for the NBA, Stanley Cup and FIFA World Club Cup – NPR

Saturday Showdown: NBA, Stanley Cup, and FIFA World Club Cup Finals Heat Up!

June 14, 2025
Trump’s Proposed Budget Would Cut a Major Ecology Program – The New York Times

Trump’s Proposed Budget Threatens Major Ecology Program with Significant Cuts

June 14, 2025
The science of sweating: Staying cool in Southern Colorado – FOX21 News Colorado

The science of sweating: Staying cool in Southern Colorado – FOX21 News Colorado

June 14, 2025
Scientists discover strong, unexpected link between Earth’s magnetic field and oxygen levels – Live Science

Scientists Uncover Surprising Connection Between Earth’s Magnetic Field and Oxygen Levels

June 14, 2025
Doctors say this lifestyle choice is the biggest contributor to cognitive decline and dementia – Earth.com

Doctors Uncover the Lifestyle Habit Most Connected to Cognitive Decline and Dementia

June 14, 2025
The economic risks of Israel’s Iran attack – Axios

The High-Stakes Economic Fallout of an Israeli Strike on Iran

June 14, 2025
The Media and Entertainment Deal Machine Is Revving Up – WSJ

The Media and Entertainment Deal Machine Is Gearing Up for Action

June 14, 2025
Kenvue mulls sale of some skin health and beauty brands, sources say – Reuters

Kenvue Explores Selling Select Skin Health and Beauty Brands to Refocus Growth

June 14, 2025
Trump’s aggressive moves on immigration protests put Democrats in a political bind – CNN

Trump’s Bold Immigration Crackdown Puts Democrats in a Tough Spot

June 14, 2025

Categories

Archives

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (685)
  • Economy (700)
  • Entertainment (21,602)
  • General (15,375)
  • Health (9,741)
  • Lifestyle (704)
  • News (22,149)
  • People (701)
  • Politics (706)
  • Science (15,917)
  • Sports (21,201)
  • Technology (15,687)
  • World (682)

Recent News

New Semiconductor Technology Could Supercharge 6G Delivery – SciTechDaily

Revolutionary Semiconductor Technology Set to Turbocharge 6G Connectivity

June 14, 2025
Saturday Sports: It’s the finals for the NBA, Stanley Cup and FIFA World Club Cup – NPR

Saturday Showdown: NBA, Stanley Cup, and FIFA World Club Cup Finals Heat Up!

June 14, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version